NASDAQ: AVXL

Corinne Lasmézas, PhD, DVM

Scientific Advisor

Corinne Lasmézas, PhD, DVM, is a professor at The Scripps Research Institute, where she has worked for over a decade. She is an internationally recognized expert in neurodegenerative diseases, focusing on the mechanisms of neurodegeneration and the role of misfolded proteins in conditions such as Alzheimer’s, Parkinson’s, and prion diseases.

Since joining Scripps in 2005, Dr. Lasmézas has led research exploring how misfolded proteins contribute to neuronal dysfunction and loss, advancing understanding in this critical area of neurobiology. Earlier in her career, she provided the first experimental evidence linking “mad cow disease” (bovine spongiform encephalopathy) to humans, identifying its role in causing variant Creutzfeldt-Jakob disease. This breakthrough highlighted the shared mechanisms of prion diseases and other age-related neurodegenerative disorders like Alzheimer’s and Parkinson’s.

During the mad cow disease crisis, Dr. Lasmézas served as an advisor to the World Health Organization (WHO) and various governmental and public health committees, offering critical insights into prion disease management. Today, she continues to contribute to the scientific community as a reviewer for major funding agencies worldwide, including the U.S. National Institutes of Health (NIH) and the UK Medical Research Council. She also advises the U.S. Food and Drug Administration (FDA), Environmental Protection Agency (EPA), and Department of Agriculture (USDA).

Dr. Lasmézas has published over 60 original scientific papers and is a frequent speaker at global scientific events, including TED Talks. She holds a PhD in Neurosciences from the University Pierre & Marie Curie in Paris, a Doctorate of Veterinary Medicine, and a Diploma of Aeronautic and Space Medicine from the University of Toulouse, France.

You are about to leave our website

By clicking “Continue,” you acknowledge that you are leaving the Anavex Life Sciences website and will be redirected to a third-party website operated by NASDAQ or its affiliates.

Anavex Life Sciences does not own, control, maintain, or endorse the content on third-party websites and is not responsible for their accuracy, completeness, or reliability. Any information available through this link is provided by third parties and does not represent the views, opinions, forecasts, or predictions of Anavex Life Sciences or its management.

The linked content is provided for informational purposes only and does not constitute investment advice or an offer to buy or sell securities. Investors should rely on their own independent judgment and consult professional advisors before making any investment decisions.